To amend the Public Health Service Act to expand research and education with respect to endometrial cancer, and for other purposes.
Summary
What This Bill Does
The bill creates congressional findings on rising incidence of endometrial cancer and racial disparities in aggressive subtypes and mortality rates, particularly affecting African-American women, amends the Public Health Service Act to add NIH endometrial cancer research expansion (Section 409K) and CDC endometrial cancer public education program (Section 399V-8), with authorized appropriations, and requires NIH endometrial cancer research expansion requiring intensified research programs, communication of disparity findings to medical professionals, and proportional representation of African-American women. It relies on authorization, program creation, declaration, and grants. The main policy areas are Healthcare, Science & Space, and Education.
Who Benefits and How
Endometrial cancer researchers could gain revenue opportunities, African-American women at disproportionate risk of endometrial cancer mortality could face reduced risk, and African-American women (targeted educational materials) would be affected.
Who Bears the Burden and How
NIH Director (new coordination duties with NICHD, NIMHD, ORWH) would take on compliance duties, CDC (new program development and dissemination duties) would take on compliance duties, and NIH (Director and affiliated institutes) would take on compliance duties.
Key Provisions
- Creates congressional findings on rising incidence of endometrial cancer and racial disparities in aggressive subtypes and mortality rates, particularly affecting African-American women.
- Amends the Public Health Service Act to add NIH endometrial cancer research expansion (Section 409K) and CDC endometrial cancer public education program (Section 399V-8), with authorized appropriations...
- Requires NIH endometrial cancer research expansion requiring intensified research programs, communication of disparity findings to medical professionals, and proportional representation of African-American women...
- Creates CDC endometrial cancer public education program requiring development and dissemination of informational materials on incidence, risk factors, ethnic minority risk, and treatments, with targeted materials...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill creates congressional findings on rising incidence of endometrial cancer and racial disparities in aggressive subtypes and mortality rates, particularly affecting African-American women, amends the Public Health Service Act to add NIH endometrial cancer research expansion (Section 409K) and CDC endometrial cancer public education program (Section 399V-8), with authorized appropriations, and requires NIH endometrial cancer research expansion requiring intensified research programs, communication of disparity findings to medical professionals, and proportional representation of African-American women.
Key Policy Areas
Healthcare, Science & Space, Education
Primary Purpose
The bill creates congressional findings on rising incidence of endometrial cancer and racial disparities in aggressive subtypes and mortality rates, particularly affecting African-American women, amends the Public Health Service Act to add NIH endometrial cancer research expansion (Section 409K) and CDC endometrial cancer public education program (Section 399V-8), with authorized appropriations, and requires NIH endometrial cancer research expansion requiring intensified research programs, communication of disparity findings to medical professionals, and proportional representation of African-American women.
Policy Domains
Whole bill
Identified Gains
- Endometrial cancer researchers
- African-American women at disproportionate risk of endometrial cancer mortality
- African-American women (targeted educational materials)
- African-American women (mandated clinical trial representation)
- Ethnic minority women at increased endometrial cancer risk
Identified Costs
- NIH Director (new coordination duties with NICHD, NIMHD, ORWH)
- CDC (new program development and dissemination duties)
- NIH (Director and affiliated institutes)
- CDC (Centers for Disease Control and Prevention)
- Eunice Kennedy Shriver NICHD, NIMHD, Office of Research on Women's Health
Sponsors
Legislative Progress
IntroducedMr. David Scott of Georgia (for himself, Ms. Clarke of …
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
African-American women (mandated clinical trial representation), African-American women (targeted educational materials), African-American women at disproportionate risk of endometrial cancer mortality
CDC (Centers for Disease Control and Prevention), CDC (new program development and dissemination duties), NIH (Director and affiliated institutes)
Endometrial cancer researchers, Endometrial cancer researchers and NIH-funded institutions
Medical professionals and researchers (improved communication of disparity data), Medical professionals treating endometrial cancer
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology